Page 8 - Evolve Biosystems News Today : Breaking News, Live Updates & Top Stories | Vimarsana

B. infantis EVC001 on key health indicators specifically in pre-term infants. The work was conducted at two neonatal intensive care units (NICU) in Southern California. "Neonatologists, neonatal nurses and other hospital-based clinical staff are acutely focused on affecting the factors that positively impact quality of care and length of stay among pre-term infants," said Dr. Karl Sylvester, Pediatric Surgeon, Stanford, California. "This study provides compelling evidence that feeding B. infantis EVC001 to preterm infants, along with human milk, yields meaningful reduction in gut dysbiosis...

Evolve BioSystems gets $55 million investment led by Cargill Evolve BioSystems has announced $55 million in funding from Cargill and a private equity firm to bring its infant probiotic to market scale. Evolve Biosystems is an independent microbiome research company that was launched out of University of California, Davis in 2014. It was initially funded  by the Bill & Melinda Gates Foundation. Also participating in the funding announced this week was investment firm Manna Tree. Evolve BioSystems has concentrated on infant gut health and the importance of the Bifi...

Evolve BioSystems Announces Major Strategic Investment from Cargill and Manna Tree to Support Innovative Probiotic That Dramatically Improves Infant Gut Health Evolve's innovative probiotic addresses widespread Newborn Gut Deficiency by restoring key bacteria in the infant gut microbiome News provided by Share this article Share this article DAVIS, Calif., Feb. 8, 2021 /PRNewswire/ -- Evolve BioSystems announced today that it completed a substantial first close in a $55 million Series D round of funding, led by Cargill, the global food, agricultural, financial and industrial products company...